Use of bioabsorbable polymers as a medical device is moving to what I think is an amazing new level. Abbott vascular announced successful initial tests of a full bioabsorbable stent used to prop open diseased coronary arteries. The device is called ABSORB because it is completely absorbed back into the body after it restores blood flow, and the blood vessel heals. Six month results for the first 30 patients in the Abbott trial showed similar rates of success as metal stents. The new stent is made of polylactic acid, which is widely used in dissolvable sutures and anchor screws. Engineers in Japan are also rapidly developing mechanical applications for PLA.
Materials and assembly methods on exhibit at next week's MD&M West and other co-located shows will include some materials you should see, as well as several new and improved processes. Here's a sampling of what you can expect.
The Food & Drug Administration has approved a 3D-printed, titanium, cranial/craniofacial patient-specific plate implant for use in the US. The implant is 3D printed using Arcam's electron beam melting (EBM) process.
The upcoming MD&M West and co-located shows in Anaheim next month will be host to a huge variety of technologies and special events like the Golden Mousetrap Awards. Here are five reasons for medtech professionals to attend.
Many of the new 3D printers and printing technologies in this slideshow are breaking some boundaries, whether it's build speed, new material types, density and quality of 3D-printed circuit board layers, or build volume in a hybrid printer. We also give some recent market statistics.
Focus on Fundamentals consists of 45-minute on-line classes that cover a host of technologies. You learn without leaving the comfort of your desk. All classes are taught by subject-matter experts and all are archived. So if you can't attend live, attend at your convenience.